Press Release Merck Announces KEYLYNK-008 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LYNPARZA® (olaparib) for Patients With Metastatic Squamous Non-Small Cell Lung Cancer to Stop for Futility 7 December 2023
Press Release Finland Alternative Lending Business Report 2023 – ResearchAndMarkets.com 7 December 2023
Press Release U.S. Urology Partners Announces Partnership with Greater Boston Urology 7 December 2023
Press Release Bristol Myers Squibb Announces Additional $3 Billion Share Repurchase Authorization 7 December 2023
Press Release KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update 7 December 2023
Press Release Nextdoor Rewind: 2023 Gives Neighbors a Local-Level Reflection of the Past Year Together 7 December 2023
Press Release Apogee Enterprises Announces Date for Fiscal 2024 Third Quarter Financial Results 7 December 2023
Press Release Global Perma-Crisis Set to Drastically Impact Employee Wellbeing in 2024, as 80% Predict Burnout Will Have a Significant Effect on Businesses – International SOS Risk Outlook 2024 7 December 2023
Press Release Denmark Alternative Lending Business and Investment Opportunities Report 2023: 75+ KPIs on Market Size, End User, Finance Model, Payment Instrument, Loan Type and Demographics 2018-2027 – ResearchAndMarkets.com 7 December 2023
